The latest data shows non-surgical options like neurotoxins and fillers are having a major moment, with both seeing significant growth in 2023. The experts aren’t surprised, and they thing injectables will only become more popular as time goes on. Why? Find out!
Featured Experts
- Norman Rowe, MD is a board-certified plastic surgeon based in New York
- David Moatazedi is CEO of Evolus, the makers of Jeuveau
- Julie Russak, MD is a board-certified dermatologist based in New York
The Latest Data from ASPS
The American Society of Plastic Surgeons is the largest organization of board-certified plastic surgeons in the world, making up more than 92 percent of all board-certified plastic surgeons in the country. Its yearly report gives us the best information on what treatments and procedures are gaining traction. And it’s clear that injectables are on the rise.
Injectables are Trending
Injectables are broken down into two main groups by the ASPS, neurotoxins and fillers. And they’ve both seen growth over the last year. Neuromodulators saw 9 percent growth in 2023, and fillers grew by 8 percent in the same time period.
“Neuromodulator injections like Botox and dermal fillers have become essential in aesthetic maintenance,” says the report, noting that over 4 million neurotoxin treatments were performed last year, including Botox®, Jeuveau®, Dysport® and Xeomin®.
These treatments in particular have a lot of uses outside of aesthetic improvement, too.
“Patients often forget that there are multiple FDA-approved uses for neurotoxins, from migraine treatments to muscle spasticity, and the safety profile has been established for use in much higher doses than needed for cosmetic effects,” says board-certified New York dermatologist Julie Russak, MD. “I often joke with my patients (being fully serious) that I feel safer with Botox injections than with taking Tylenol.”
And in the world of fillers, we’re seeing some interesting specifics.
According to the report, the 40-55 age group has seen a “significant increase in the use of non-hyaluronic acid fillers, accounting for 35 percent of these procedures.” And patients ages 30-39 “saw the highest year-over-year increase in hyaluronic acid fillers, with an 8.93 percent rise.”
Why are Neurotoxins and Filler on the Rise?
“They appeal to all age groups,” explains New York plastic surgeon Norman Rowe, MD. “They offer an alternative for someone who only wants a modest change and/or is not quite ready for a surgical procedure.”
It’s not just any age that these treatments appeal to though. According to the data, more and more men are getting neurotoxin treatments, with “Brotox” growing by 5.55 percent in 2023.
“We’ve been seeing the steady rise in demand of neurotoxins from men, which is not entirely surprising given the desire to maintain a youthful appearance is not gender specific,” explains CEO of Evolus (the makers of Jeuveau) David Moatazedi. “In fact, last summer we unveiled new creative to be inclusive of our increasingly diversified customers.”
In addition to their wide appeal, injectables like filler and neurotoxins have only gotten better in their formulations.
“Nonsurgical options have always been popular and will continue to be so,” Dr. Rowe says. “The injectables have gotten better, more reliable and longer lasting. Its a win, win, win.”
How Much do Injectables Cost?
The ASPS Trend report is also a great way to keep up to date with the changing cost of treatments.
How much does neurotoxin cost?
The amount of neuromodulator needed depends on what a patient’s goals are, but they are largely considered one of the most affordable options for aesthetic treatment. In 2023, neurotoxin treatment costs on average $435, down from 2022’s average of $528.
How much does filler cost?
How much filler costs will depend on what kind you’re looking for. Non-hyaluronic acid fillers (Radiesse®, Sculptra®,
Bellafill®, Renuva®) averaged $901 in 2023, down from 2022’s average of $1,039.
Hyaluronic acid fillers (like Juvederm Ultra® or Restylane®) averaged $715 in 2023, down from $794 in 2022.
